FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000864757> ?p ?o ?g. }

• W2000864757 endingPage "588" @default.
• W2000864757 startingPage "581" @default.
• W2000864757 abstract "The association of increasing serum levels of fibrinogen degradation products after recombinant tissue-type plasminogen activator (rt-PA) therapy with bleeding and early coronary patency was assessed in 242 patients with acute myocardial infarction. After administration of 5,000 IU heparin, a median of 40 mg (range 35 to 60) of double chain rt-PA was given intravenously in 90 min. Bleeding occurred in 62 patients; in 73% of patients it was observed within the 1st 24 h and 84% of events consisted of hematoma or prolonged bleeding, or both, at puncture sites. Bleeding events occurred 2.12 times as often in patients with serum levels of fibrinogen degradation products >85 mg/liter as in patients with serum levels <22 mg/liter (95% confidence interval 1.01 to 4.43). The infarct-related coronary vessel was patent in 65% of patients at 90 min after the start of rt-PA infusion. In patients with high serum levels of fibrin(ogen) degradation products, coronary patency at 90 min after the start of rt-PA infusion was not better (13% less, 95% confidence interval −33%, 13%) than in patients with low serum levels. This uncoupling of thrombolytic effect in terms of coronary patency and systemic fibrinogenolysis confirms the experimentally demonstrated fibrin specificity of double chain rt-PA in human subjects. Because fibrin specificity of single chain rt-PA is at least similar to that of double chain rt-PA, the observations in this analysis most likely hold also for single chain rt-PA. These findings suggest that a dose of rt-PA just below the threshold that causes systemic fibrinogenolysis might be optimal in terms of bleeding and coronary patency. Measurements of fibrinogen degradation products during rt-PA infusion might help to titrate rt-PA dosing in individual patients." @default.
• W2000864757 created "2016-06-24" @default.
• W2000864757 creator A5000861878 @default.
• W2000864757 creator A5001446916 @default.
• W2000864757 creator A5005013828 @default.
• W2000864757 creator A5015610233 @default.
• W2000864757 creator A5023982501 @default.
• W2000864757 creator A5029363108 @default.
• W2000864757 creator A5049260728 @default.
• W2000864757 creator A5058327516 @default.
• W2000864757 date "1989-09-01" @default.
• W2000864757 modified "2023-09-24" @default.
• W2000864757 title "Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency" @default.
• W2000864757 cites W1533600198 @default.
• W2000864757 cites W1965471018 @default.
• W2000864757 cites W1977288751 @default.
• W2000864757 cites W1977967610 @default.
• W2000864757 cites W1983126671 @default.
• W2000864757 cites W1986774920 @default.
• W2000864757 cites W1989504164 @default.
• W2000864757 cites W2017731963 @default.
• W2000864757 cites W2047104203 @default.
• W2000864757 cites W2078635736 @default.
• W2000864757 cites W2083147570 @default.
• W2000864757 cites W2085869089 @default.
• W2000864757 cites W2093322042 @default.
• W2000864757 cites W2093923223 @default.
• W2000864757 cites W2114742226 @default.
• W2000864757 cites W2129127648 @default.
• W2000864757 cites W2142993715 @default.
• W2000864757 cites W2160443953 @default.
• W2000864757 cites W2322445769 @default.
• W2000864757 cites W2327355331 @default.
• W2000864757 doi "https://doi.org/10.1016/0735-1097(89)90096-x" @default.
• W2000864757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2504798" @default.
• W2000864757 hasPublicationYear "1989" @default.
• W2000864757 type Work @default.
• W2000864757 sameAs 2000864757 @default.
• W2000864757 citedByCount "38" @default.
• W2000864757 countsByYear W20008647572013 @default.
• W2000864757 countsByYear W20008647572014 @default.
• W2000864757 countsByYear W20008647572015 @default.
• W2000864757 crossrefType "journal-article" @default.
• W2000864757 hasAuthorship W2000864757A5000861878 @default.
• W2000864757 hasAuthorship W2000864757A5001446916 @default.
• W2000864757 hasAuthorship W2000864757A5005013828 @default.
• W2000864757 hasAuthorship W2000864757A5015610233 @default.
• W2000864757 hasAuthorship W2000864757A5023982501 @default.
• W2000864757 hasAuthorship W2000864757A5029363108 @default.
• W2000864757 hasAuthorship W2000864757A5049260728 @default.
• W2000864757 hasAuthorship W2000864757A5058327516 @default.
• W2000864757 hasBestOaLocation W20008647572 @default.
• W2000864757 hasConcept C126322002 @default.
• W2000864757 hasConcept C141071460 @default.
• W2000864757 hasConcept C164705383 @default.
• W2000864757 hasConcept C176674119 @default.
• W2000864757 hasConcept C203014093 @default.
• W2000864757 hasConcept C2776825266 @default.
• W2000864757 hasConcept C2777557582 @default.
• W2000864757 hasConcept C2779036427 @default.
• W2000864757 hasConcept C2779679481 @default.
• W2000864757 hasConcept C2909373784 @default.
• W2000864757 hasConcept C500558357 @default.
• W2000864757 hasConcept C54173615 @default.
• W2000864757 hasConcept C71924100 @default.
• W2000864757 hasConcept C89560881 @default.
• W2000864757 hasConcept C90924648 @default.
• W2000864757 hasConceptScore W2000864757C126322002 @default.
• W2000864757 hasConceptScore W2000864757C141071460 @default.
• W2000864757 hasConceptScore W2000864757C164705383 @default.
• W2000864757 hasConceptScore W2000864757C176674119 @default.
• W2000864757 hasConceptScore W2000864757C203014093 @default.
• W2000864757 hasConceptScore W2000864757C2776825266 @default.
• W2000864757 hasConceptScore W2000864757C2777557582 @default.
• W2000864757 hasConceptScore W2000864757C2779036427 @default.
• W2000864757 hasConceptScore W2000864757C2779679481 @default.
• W2000864757 hasConceptScore W2000864757C2909373784 @default.
• W2000864757 hasConceptScore W2000864757C500558357 @default.
• W2000864757 hasConceptScore W2000864757C54173615 @default.
• W2000864757 hasConceptScore W2000864757C71924100 @default.
• W2000864757 hasConceptScore W2000864757C89560881 @default.
• W2000864757 hasConceptScore W2000864757C90924648 @default.
• W2000864757 hasIssue "3" @default.
• W2000864757 hasLocation W20008647571 @default.
• W2000864757 hasLocation W20008647572 @default.
• W2000864757 hasLocation W20008647573 @default.
• W2000864757 hasOpenAccess W2000864757 @default.
• W2000864757 hasPrimaryLocation W20008647571 @default.
• W2000864757 hasRelatedWork W1983567391 @default.
• W2000864757 hasRelatedWork W2004316159 @default.
• W2000864757 hasRelatedWork W2022372977 @default.
• W2000864757 hasRelatedWork W2031298845 @default.
• W2000864757 hasRelatedWork W2401963788 @default.
• W2000864757 hasRelatedWork W2408511292 @default.
• W2000864757 hasRelatedWork W2413550539 @default.
• W2000864757 hasRelatedWork W2414694704 @default.
• W2000864757 hasRelatedWork W2417756525 @default.
• W2000864757 hasRelatedWork W4250375462 @default.

• next